Diana Brainard Insider Profile

4 Followers
Diana Brainard, CEO, Director at AlloVir, holds 742.68K shares in AlloVir (Ticker: ALVR), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of AlloVir on Oct 23, 2024 for an estimated value of 7.51K.
tipranks
Diana Brainard

Diana Brainard
AlloVir (ALVR)
CEO, Director

Ranked #30,351 out of 99,218 Corporate Insiders

Profitable Transactions

31%
8 out of 26 Profitable Transactions

Average Return

+1.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$743K
95.27%
4.73%
A breakdown of Diana Brainard's holdings

Insider Roles

AlloVir
(ALVR)
CEO, Director
Nektar Therapeutics
(NKTR)
Director
Roles that Diana Brainard holds in companies

Most Profitable Insider Trade

Stock:
AlloVir
(ALVR)
Rating:Informative Sell
Date:May 19, 2023 - May 19, 2024
Return:+81.50%
The most profitable trade made by Diana Brainard

Diana Brainard's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AlloVir
Oct 23, 2024
CEO, Director
Informative Sell
7.51K
$707.77K
Nektar Therapeutics
Sep 20, 2022
Director
Uninformative Buy
$35.13K
List of latest transactions for each holding click on a transaction to see Diana Brainard's performance on stock

Diana Brainard insider profile FAQ

What is the percentage of profitable transactions made by Diana Brainard?
The percentage of profitable transactions made by Diana Brainard is 31%.
    What is the average return per transaction made by Diana Brainard?
    The average return per transaction made by Diana Brainard is 1.60%.
      What stocks does Diana Brainard hold?
      Diana Brainard holds: ALVR, NKTR stocks.
        What was Diana Brainard’s latest transaction?
        Diana Brainard latest transaction was an Informative Sell of $7.51K.
          What was Diana Brainard's most profitable transaction?
          Diana Brainard’s most profitable transaction was an Informative Sell of ALVR stock on May 19, 2023. The return on the trade was 81.50%.
            What is Diana Brainard's role in AlloVir?
            Diana Brainard's role in AlloVir is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.